跳至主要内容
临床试验/CTRI/2025/07/091372
CTRI/2025/07/091372已完成不适用

A Clinical study to evaluate the efficacy of Narie PCOS in the management of Poly Cystic Ovarian Syndrome (Aarthava Akshaya)

Zeroharm Science Private Limited1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年8月4日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Assessment Criteria (Based on Grade & Score) 1. Duration of bleeding

研究概览

简要总结

The eligible patients of PCOS will be treated with Narie PCOS an ayurvedic medicine for a duration of three months. Two follow ups will be carried out at the interval of 1 month. Before and After the treatment, laboratory investigations will be carried out to find out the improvements of the patients.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Patient diagnosed with PCOS
  • Patient with chief complain of Irregular menses / scanty menses
  • Patients suffer infertility due to PCOS.
  • 4.Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

排除标准

  • Pregnant or Lactating women Congenital anomalies in female genital tract or Congenital adrenal hyperplasia Malignant diseased patients and cytotoxic patients.

结局指标

主要结局

Assessment Criteria (Based on Grade & Score) 1. Duration of bleeding

时间窗: 12 weeks

2. Irregular menstruation

时间窗: 12 weeks

3. Amount of bleeding and quantity of menstrual blood

时间窗: 12 weeks

4. Pain during menstrual period

时间窗: 12 weeks

次要结局

  • 1. Haematological- CBC, ESR, Blood group, Urine (R/M), LH,FSH(Follicular study- A serial vaginal or abdominal sono graphy was done from 10th day of menstrual cycle,till after ovulation.)

研究者

发起方
Zeroharm Science Private Limited
申办方类型
Other [Neutracutical company ]
责任方
Principal Investigator
主要研究者

Dr Dipak Kumar Goswami

Government Ayurvedic College, Jalukbari, Guwahati -14 , Assam

研究点 (1)

Loading locations...

相似试验